News

Health and Human Services Secretary Robert F. Kennedy Jr. has been a vocal critic of drugs like Ozempic which he said cloud ...
The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Kennedy Jr., has been an outspoken opponent of the injectable drugs, which have exploded in popularity due to the ...
The Centers for Medicare and Medicaid Services recently ... a proposal initiated by the Biden Administration to cover weight-loss drugs like Wegovy and Zepbound for its beneficiaries.
The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...
Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...
In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...
Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.
President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...